Want to see more of NewsNation? Get 24/7 fact-based news coverage with the NewsNation app or add NewsNation as a preferred source on Google !

(Reuters) – WeightWatchers’ CEO said Wednesday the company plans to sell Novo Nordisk’s much-anticipated Wegovy in pill form if it is launched next year in the United States, deepening its tie-up with the Danish obesity drugmaker .

The collaboration is a potential boost for WeightWatchers as it emerges from bankruptcy and highlights its commitment to sell branded obesity drugs, unlike rivals that push cheaper copies in a highly competitive market.

“We have been working with Novo Nordisk ahead of time to support the launch of oral weight-loss medication,” WeightWatchers CEO Tara Comonte said in an interview.

“A

See Full Page